Daejeon, South Korea

Dong Jun Yeo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2015.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dong Jun Yeo

Introduction

Dong Jun Yeo is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical formulations. His work focuses on developing innovative solutions that enhance the efficacy and safety of injectable medications.

Latest Patents

One of Dong Jun Yeo's notable patents is titled "Non-aqueous oily injectable formulation exhibiting preservative efficacy." This patent discloses a multi-dose type non-aqueous oily injectable formulation. It includes an active ingredient that expresses therapeutic effects, which is dissolved, dispersed, or suspended in a therapeutically effective amount of oil. The formulation may also contain an oil-affinitive preservative and a hydrophilic excipient that remains non-phase separable from the oil-affinitive preservative when mixed.

Career Highlights

Dong Jun Yeo is associated with LG Life Sciences, Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in formulation science has positioned him as a valuable asset in the research and development of new therapeutic products.

Collaborations

Throughout his career, Dong Jun Yeo has collaborated with several talented individuals, including Jin Eon So and Yoon-Seon Jang. These collaborations have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Dong Jun Yeo's contributions to the field of pharmaceutical formulations exemplify the importance of innovation in healthcare. His work continues to pave the way for advancements in injectable medications, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…